Malaria Vaccine Study for Women Who Could Become Pregnant in Mali
Part of Infections clinical trials.
This study tests an experimental malaria vaccine called PfSPZ-LARC2. Researchers want to learn if it is safe and effective for women who could become pregnant, especially in Mali where malaria is common. You would receive several doses of the vaccine and be followed for a few months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 38 and could become pregnant
- You are in good general health with no major medical issues
- You are willing to use reliable birth control during the study period
- You have not received an experimental malaria vaccine in the past 10 years
- You do not have HIV, hepatitis, or certain chronic conditions
- You are interested in possibly becoming pregnant within the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new malaria vaccine to see if it is safe and how the body responds. It involves healthy adults in Burkina Faso who will be monitored closely after vaccination.
This study tests a new malaria vaccine called PfSPZ-LARC2 in healthy adults living in Burkina Faso. If you qualify, the vaccine is given to see if it can protect you from malaria.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
This study looks at lab tests for malaria vaccine candidates in pregnant women who currently have malaria. It may help researchers understand which vaccine approaches are safest and most promising for pregnancy.
This registry is collecting information about pregnancies in Mali to help improve health for mothers and babies. You can join either as part of a general community survey or as a pregnant woman receiving care at a health center in Kalifabougou.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.